HK1125407A1 - Dna constructs for specific inhibition of gene expression by rna interference rna dna - Google Patents

Dna constructs for specific inhibition of gene expression by rna interference rna dna

Info

Publication number
HK1125407A1
HK1125407A1 HK09104334.8A HK09104334A HK1125407A1 HK 1125407 A1 HK1125407 A1 HK 1125407A1 HK 09104334 A HK09104334 A HK 09104334A HK 1125407 A1 HK1125407 A1 HK 1125407A1
Authority
HK
Hong Kong
Prior art keywords
dna
rna
gene expression
specific inhibition
rna interference
Prior art date
Application number
HK09104334.8A
Other languages
English (en)
Chinese (zh)
Inventor
‧施羅夫
‧奧斯拉德
Original Assignee
莫洛根股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 莫洛根股份公司 filed Critical 莫洛根股份公司
Publication of HK1125407A1 publication Critical patent/HK1125407A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/52—Physical structure branched
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK09104334.8A 2005-11-25 2009-05-12 Dna constructs for specific inhibition of gene expression by rna interference rna dna HK1125407A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025727 2005-11-25
PCT/DE2006/002083 WO2007059760A1 (de) 2005-11-25 2006-11-22 Dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz

Publications (1)

Publication Number Publication Date
HK1125407A1 true HK1125407A1 (en) 2009-08-07

Family

ID=37776452

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104334.8A HK1125407A1 (en) 2005-11-25 2009-05-12 Dna constructs for specific inhibition of gene expression by rna interference rna dna

Country Status (13)

Country Link
US (1) US9012620B2 (ja)
EP (1) EP1951870B1 (ja)
JP (1) JP5186381B2 (ja)
CN (1) CN101313067B (ja)
AU (1) AU2006317222B2 (ja)
BR (1) BRPI0618907A2 (ja)
CA (1) CA2627443C (ja)
DE (1) DE112006003704A5 (ja)
DK (1) DK1951870T3 (ja)
ES (1) ES2421314T3 (ja)
HK (1) HK1125407A1 (ja)
RU (1) RU2410431C2 (ja)
WO (1) WO2007059760A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1716234B1 (de) * 2004-02-20 2013-10-02 Mologen AG Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren
WO2010090452A2 (ko) * 2009-02-04 2010-08-12 성균관대학교산학협력단 세포 내 전달능이 증가된 작은 간섭 rna 복합체
EP2438168B1 (en) * 2009-06-01 2020-02-12 Halo-Bio Rnai Therapeutics, Inc. Polynucleotides for multivalent rna interference, compositions and methods of use thereof
US8889646B2 (en) 2009-06-03 2014-11-18 Regado Biosciences, Inc. Nucleic acid modulators of glycoprotein VI
US8889645B2 (en) 2009-06-03 2014-11-18 Regado Biosciences, Inc. Nucleic acid modulators of glycoprotein VI
AU2010256511B2 (en) * 2009-06-03 2016-01-14 Tobira Therapeutics, Inc. Nucleic acid modulators of glycoprotein VI
WO2017035278A1 (en) 2015-08-24 2017-03-02 Halo-Bio Rnai Therapeutics, Inc. Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
EP3500682B1 (en) * 2016-08-16 2020-07-08 Touchlight IP Limited Closed linear dna production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059016A1 (en) * 2002-11-05 2005-03-17 Ecker David J. Structural motifs and oligomeric compounds and their use in gene modulation
DE19648625A1 (de) 1996-11-13 1998-05-14 Soft Gene Gmbh Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
DE10048417A1 (de) 2000-09-29 2002-04-11 Roche Diagnostics Gmbh Verbindungen mit verzweigtem Linker
US20040053876A1 (en) * 2002-03-26 2004-03-18 The Regents Of The University Of Michigan siRNAs and uses therof
ES2280829T3 (es) * 2002-07-19 2007-09-16 Mologen Ag Constructo de expresion de adn para la expresion de multiples genes.
US20090004703A1 (en) * 2004-05-28 2009-01-01 Mologen Ag Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference

Also Published As

Publication number Publication date
EP1951870A1 (de) 2008-08-06
US9012620B2 (en) 2015-04-21
BRPI0618907A2 (pt) 2012-04-17
CA2627443A1 (en) 2007-05-31
US20080311630A1 (en) 2008-12-18
CA2627443C (en) 2013-10-01
ES2421314T3 (es) 2013-08-30
AU2006317222A1 (en) 2007-05-31
RU2410431C2 (ru) 2011-01-27
WO2007059760A1 (de) 2007-05-31
CN101313067B (zh) 2014-04-02
EP1951870B1 (de) 2013-04-24
RU2008125849A (ru) 2009-12-27
AU2006317222B2 (en) 2011-06-30
DK1951870T3 (da) 2013-07-29
JP5186381B2 (ja) 2013-04-17
JP2009521210A (ja) 2009-06-04
DE112006003704A5 (de) 2008-10-23
CN101313067A (zh) 2008-11-26

Similar Documents

Publication Publication Date Title
HK1125407A1 (en) Dna constructs for specific inhibition of gene expression by rna interference rna dna
IL190114A0 (en) Inhibition of viral gene expression using small interfering rna
HK1200487A1 (en) Silencing of csn5 gene expression using interfering rna rna csn5
ZA200908342B (en) Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
EP1742958A4 (en) METHODS AND COMPOSITIONS FOR SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE STRANDED RNA
EP2601293A4 (en) CATENIN RNA INTERFERENCE-INHIBITING INHIBITION (CADHERIN-ASSOCIATED PROTEIN), EXPRESSION OF BETA-1 GENE (CTNNB1) USING SMALL INTERFERING NUCLEIC ACID (SIAN)
EP2050819A4 (en) NUCLEOTIDE-amplification
EP2172547A4 (en) PROCESS FOR EXPRESSING A SPECIFIC GENE
EP1957648A4 (en) MODULATION OF GENE EXPRESSION BY TARGET OLIGOMERS TO CHROMOSOMIC DNA
EP2238251A4 (en) SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERENCE RNA
EP2064223A4 (en) BICATENARY OLIGONUCLEOTIDE COMPLEXES AND METHODS FOR SILENCING GENES BY RNA INTERFERENCE
IL194290A0 (en) Small internally segmented interfering rna
HK1086036A1 (en) Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
EP1842558A4 (en) COMPOSITION FOR INHIBITING THE EXPRESSION OF A TARGET
GB0711675D0 (en) Labelling of RNA
IL186689A0 (en) Methods of enhancing isolation of rna from biological samples
GB0507997D0 (en) Nucleic acid constructs
IL183622A0 (en) Methods for simplifying microbial nucleic acids by chemical modification of cytosines
AU2003297474A8 (en) Methods of inhibiting gene expression by rna interference
GB0609420D0 (en) Method of gene transfer
ZA200801099B (en) Chemically modified short interfering nucleic acid molecules that mediate rna interference
HK1073669A1 (en) Nucleic acid constructs for gene expression
IL186142A0 (en) Gene sythesis using pooled dna
DK1749096T3 (da) Fremgangsmåde til fremstilling af egnede DNA-konstrukter til specifik inhibering af genekspression ved RNA-interferens
IL189540A0 (en) Chemically modified short interfering nucleic acid molecules that mediate rna interference

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181122